Abstract
Over activation of poly (ADP-ribose) polymerase has been involved in the pathogenesis of several diseases including stroke, myocardial infarction, diabetes, shock, neurodegenerative disorder, allergy, and several other inflammatory processes. Owing to the dual response of PARP-1 to DNA damage and its involvement in cell death, pharmacological modulation of PARP-1 activity may constitute a useful tool to increase the activity of DNA-binding antitumor drugs. Quantitative structure activity relationship (QSAR) study vis-à-vis physico-chemical parameters and forward feed neural network analysis for a series of phthalazinone derivatives as potent inhibitors of poly (ADP-ribose) polymerase was performed. The result of QSAR studies obtained allows us to recognize such physico-chemical parameters of phthalazinone derivatives which can be strictly related to the PARP-1 inhibitory activity.
Similar content being viewed by others
References
Costantino G (2001) Modeling of poly(ADP-ribose)polymerase (PARP) inhibitors. Docking of ligands and quantitative structure–activity relationship analysis. J Med Chem 44:3786–3794
D’Amours D, Desnoyers S, D’Silva I, Poirier GG (1999) Poly(ADPribosyl)ation reactions in the regulation of nuclear functions. Biochem J 342:249–268
Griffin RJ, Pemberton LC, Rhodes D, Bleasdale C, Bowman K, Calvert AH, Curtin NJ, Durkacz BW, Newell DR, Porteous JK, Golding BT (1995) Anticancer Drug Des 10:507–514
Lautier DJ, Lagueaux J, Thibodeau LM, Poirier GG (1993) Molecular and biochemical features of poly (ADP-ribose) metabolism. Mol Cell Biochem 122(2):171–193
Lindahl T, Satoh MS, Poirier GG, Klungland A (1995) Posttranslational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks. Trends Biochem Sci 20(10):405–411
Loh VM, Cockcroft X, Dillon KJ, Dixon L, Drzewiecki J, Eversley PJ, Gomez S, Hoare J, Kerrigan F, Matthews ITW, Menear KA, Martin NMB, Newton RF, Paul J, Smith GCM, Vilec J, Whittlec AJ (2005) Phthalazinones. Part 1: the design and synthesis of a novel series of potent inhibitors of poly (ADP-ribose) polymerase. Bioorg Med Chem Lett 15(2):235–2238
Martin DS, Bertino JR, Koutcher JA (2000) ATP depletion + pyrimidine depletion can markedly enhance cancer therapy: fresh insight for a new approach. Cancer Res 60(24):6776–6783
Murthy VS, Kulkarni VM (2002) 3D-QSAR CoMFA and CoMSIA on protein tyrosine phosphatase 1B inhibitors. Bioorg Med Chem 10:2267–2282
Ogata N, Ueda K, Kawaichi M, Hayaishi O (1981) Poly(ADP-ribose) synthetase, a main acceptor of poly(ADP-ribose) in isolated nuclei. J Biol Chem 256:4135–4137
Puntambekar D, Giridhar R, Yadav MR (2006) 3D-QSAR studies of farnesyltransferase inhibitors: a comparative molecular field analysis approach. Bioorg Med Chem Lett 16:1821–1827
Purnell MR, Whish WJD (1980) Novel inhibitors of poly(ADP-ribose)synthetase. Biochem J 185:775
Skalitzky DJ, Marakovits JT, Maegley KA (2003) Tricyclic benzimidazoles as potent poly(ADP-ribose) polymerase-1 inhibitors. J Med Chem 46(2):210–213
Southan GJ, Szabo C (2003) Poly(ADP-ribose) polymerase inhibitors. Curr Med Chem 10(4):321–340
Srivastava AK (2008) Quantitative structure activity relationship studies on a novel series of phthalazinone as potent poly(ADP-ribose) polymerase inhibitors. Proc Natl Acad Sci India Sect A 78A:37–44
Suto MJ, Turner WR, Arundel-Suto CM, Werbel LM, Sebolt-Leopold JS (1991) Dihydroisoquinolinones: the design and synthesis of a new series of potent inhibitors of poly(ADP-ribose) polymerase. Anticancer Drug Des 6:107–117
Tentori L, Portarena I, Graziani G (2002) Potential clinical applications of poly(ADP-ribose) polymerase (PARP) inhibitors. Pharmacol Res 45(2):73–85
Zupan J, Gasteiger J (1993) Neural networks for chemists: an introduction. VCH, Weinheim
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rewatkar, P.V., Kokil, G.R. & Raut, M.K. QSAR studies of phthalazinones: novel inhibitors of poly (ADP-ribose) polymerase. Med Chem Res 20, 877–886 (2011). https://doi.org/10.1007/s00044-010-9414-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-010-9414-2